{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:21:51Z","timestamp":1767651711293,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jbspin.2020.07.002","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T11:49:04Z","timestamp":1594813744000},"page":"105053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pop a pill or give myself a shot? Patient perspectives of disease-modifying anti-rheumatic drug choice for rheumatoid arthritis"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-0006","authenticated-orcid":false,"given":"Jasvinder A.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley","family":"Tornberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2020.07.002_bib0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.27227","volume":"62","author":"Hetland","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0210","first-page":"350","article-title":"Understanding the patient perspective \u2013 results of the Rheumatoid Arthritis: Insights, Strategies & Expectations (RAISE) patient needs survey","volume":"31","author":"McInnes","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0215","first-page":"1079","article-title":"Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making","volume":"10","author":"Bolge","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0220","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/1756-185X.13514","article-title":"Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study","volume":"22","author":"Benham","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0225","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/rheumatology\/key205","article-title":"The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study","volume":"57","author":"Verhoef","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0230","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00296-017-3760-z","article-title":"Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective","volume":"37","author":"Husni","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/PPA.S70834","article-title":"Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective","volume":"9","author":"Bolge","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0240","first-page":"78","article-title":"Perspective of the patient with rheumatoid arthritis on issues related to missed medication","volume":"3","author":"Lorish","year":"1990","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0245","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2147\/PPA.S66849","article-title":"Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis","volume":"8","author":"Zwikker","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0250","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1532-5415.1999.tb04575.x","article-title":"Medication adherence in rheumatoid arthritis patients: older is wiser","volume":"47","author":"Park","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0255","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/1756-185X.13660","article-title":"Rheumatologists\u2019 insight into medication adherence in patients with rheumatoid arthritis: A qualitative study","volume":"22","author":"Heidari","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0260","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semarthrit.2017.12.010","article-title":"Do out-of-pocket costs affect medication adherence in adults with rheumatoid arthritis? A systematic review","volume":"48","author":"Heidari","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0265","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/08870446.2016.1139111","article-title":"\u2019The lesser of two evils.\u2019 - views of persons with rheumatoid arthritis on medication adherence: a qualitative study","volume":"31","author":"Brandstetter","year":"2016","journal-title":"Psychol Health"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0270","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.5888\/pcd15.180218","article-title":"Self-efficacy and adherence behaviors in rheumatoid arthritis patients","volume":"15","author":"Oshotse","year":"2018","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0275","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1080\/09638288.2016.1212111","article-title":"A longitudinal, qualitative study exploring sustained adherence to a hand exercise programme for rheumatoid arthritis evaluated in the SARAH trial","volume":"39","author":"Nichols","year":"2017","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0280","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2147\/PPA.S174672","article-title":"Exploring strategies to support medication adherence in patients with inflammatory arthritis: a patient-oriented qualitative study using an interactive focus group activity","volume":"12","author":"Rai","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0285","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13075-018-1732-7","article-title":"I do not want to suppress the natural process of inflammation: new insights on factors associated with non-adherence in rheumatoid arthritis","volume":"20","author":"Ritschl","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0290","doi-asserted-by":"crossref","first-page":"e114350","DOI":"10.1371\/journal.pone.0114350","article-title":"Fears and beliefs in rheumatoid arthritis and spondyloarthritis: a qualitative study","volume":"9","author":"Berenbaum","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0295","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/acr.23541","article-title":"Experience and Context Shape Patient and Clinician Goals For Treatment of Rheumatoid Arthritis: A Qualitative Study","volume":"70","author":"Barton","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0300","doi-asserted-by":"crossref","first-page":"e002164","DOI":"10.1136\/bmjopen-2012-002164","article-title":"A qualitative interview study: patient accounts of medication use in early rheumatoid arthritis from symptom onset to early postdiagnosis","volume":"3","author":"Townsend","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0305","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/rheumatology\/keu523","article-title":"Young people's decisions about biologic therapies: who influences them and how?","volume":"54","author":"Hart","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0310","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/jme.2007.023705","article-title":"Information and participation in decision-making about treatment: a qualitative study of the perceptions and preferences of patients with rheumatoid arthritis","volume":"34","author":"Schildmann","year":"2008","journal-title":"J Med Ethics"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0315","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/ard.2003.019422","article-title":"Patient preferences for treatment of rheumatoid arthritis","volume":"63","author":"Fraenkel","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0320","first-page":"84","article-title":"Patient preferences regarding rheumatoid arthritis therapies: a conjoint analysis","volume":"9","author":"Louder","year":"2016","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0330","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/acr.23758","article-title":"Patient Perspectives on intravenous biologics for rheumatologic disease","volume":"71","author":"Grisanti","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0335","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2017-212407","article-title":"Preference phenotypes to facilitate shared decision-making in rheumatoid arthritis","volume":"77","author":"Fraenkel","year":"2018","journal-title":"Ann Rheum Dis"},{"year":"2018","series-title":"Factors related to initiation of TNF inhibitor versus triple therapy in rheumatoid arthritis patients","author":"Jin","key":"10.1016\/j.jbspin.2020.07.002_bib0340"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0345","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0350","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0355","doi-asserted-by":"crossref","DOI":"10.1177\/014572170002600211","article-title":"Nominal group technique: a process for identifying diabetes self-care issues among patients and caregivers","volume":"26","author":"Miller","year":"2000","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0360","first-page":"13","article-title":"A fresh approach to group goal setting. The three-way rotation nomimal group technique","volume":"2","author":"Hegger","year":"1986","journal-title":"J Nurs Staff Dev"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0365","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/fampra\/10.1.76","article-title":"The nominal group technique: a research tool for general practice?","volume":"10","author":"Gallagher","year":"1993","journal-title":"Family Practice"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0370","article-title":"Patient and caregiver priorities for medication adherence in gout, osteoporosis and rheumatoid arthritis: nominal group technique","author":"Kelly","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0375","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jbspin.2020.02.009","article-title":"Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA)","volume":"87","author":"Singh","year":"2020","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0380","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/rheumatology\/kel369","article-title":"Patient preferences in choosing anti-TNF therapies-R1","volume":"45","author":"Williams","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0385","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/ard.2006.068296","article-title":"Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)","volume":"66","author":"Goekoop-Ruiterman","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0390","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/acr.21657","article-title":"Decision tool to improve the quality of care in rheumatoid arthritis","volume":"64","author":"Fraenkel","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0395","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12911-014-0104-8","article-title":"The design of a low literacy decision aid about rheumatoid arthritis medications developed in three languages for use during the clinical encounter","volume":"14","author":"Barton","year":"2014","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.jbspin.2020.07.002_bib0400","doi-asserted-by":"crossref","first-page":"e1002800","DOI":"10.1371\/journal.pmed.1002800","article-title":"Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): a randomized controlled trial","volume":"16","author":"Singh","year":"2019","journal-title":"PLoS Med"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X2030138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X2030138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:27:01Z","timestamp":1761150421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X2030138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1297319X2030138X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2020.07.002","relation":{},"ISSN":["1297-319X"],"issn-type":[{"type":"print","value":"1297-319X"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pop a pill or give myself a shot? Patient perspectives of disease-modifying anti-rheumatic drug choice for rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2020.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"105053"}}